Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, P. I.
Right arrow Articles by Sanders, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, P. I.
Right arrow Articles by Sanders, D. B.
NEUROLOGY 1993;43:977
© 1993 American Academy of Neurology

Acetylcholine receptor antibodies in juvenile myasthenia gravis

P. Ian Andrews, FRACP, Janice M. Massey, MD and Donald B. Sanders, MD

Departments of Pediatrics (Dr. Andrews) and Neurology (Drs. Massey and Sanders), Duke University Medical Center, Durham, NC.

We analyzed relationships among pubertal stage at disease onset, sex, disease severity, and acetylcholine receptor antibody (AChR Ab) levels in 46 patients with autoimmune juvenile myasthenia gravis (JMG). Female predominance was least in children with prepubertal disease onset (F:M = 1.3:1) and increased in patients with peripubertal (F:M = 1.8:1) and postpubertal (F:M = 14:1) onset. Seronegative JMG was most common in children with early disease onset: 4 of 9 (44%) with prepubertal, 4 of 22 (18%) with peripubertal, and 0 of 15 (0%) with postpubertal onset were seronegative. The rapid therapeutic response to plasmapheresis was useful in distinguishing some patients with seronegative JMG from those with congenital myasthenia gravis (CMG). The high frequency of seronegative JMG in patients with prepubertal onset indicates that AChR Ab assays do not adequately discriminate between JMG and CMG in young children. Furthermore, the different sex distribution in patients with different pubertal stages at disease onset suggests that sex hormones play an important modulating role in JMG.

Address correspondence and reprint requests to Dr. P. Ian Andrews, Box 3533, Duke University Medical Center, Durham, NC 27710.

Received July 7, 1992. Accepted for publication in final form September 9, 1992.




This article has been cited by other articles:


Home page
J Child NeurolHome page
C.-Y. Tsao, J. R. Mendell, W. D. Lo, M. Luquette, and R. Rennebohm
Myasthenia Gravis and Associated Autoimmune Diseases in Children
J Child Neurol, November 1, 2000; 15(11): 767 - 769.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.